nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—SHBG—hindlimb—amyotrophic lateral sclerosis	0.0269	0.106	CbGeAlD
Danazol—GNRHR—hindbrain—amyotrophic lateral sclerosis	0.0269	0.106	CbGeAlD
Danazol—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0548	CcSEcCtD
Danazol—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0171	0.0456	CcSEcCtD
Danazol—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0439	CcSEcCtD
Danazol—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0439	CcSEcCtD
Danazol—GNRHR—brainstem—amyotrophic lateral sclerosis	0.0154	0.0609	CbGeAlD
Danazol—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0354	CcSEcCtD
Danazol—CCL2—embryo—amyotrophic lateral sclerosis	0.0132	0.0519	CbGeAlD
Danazol—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0331	CcSEcCtD
Danazol—SHBG—hindbrain—amyotrophic lateral sclerosis	0.0123	0.0484	CbGeAlD
Danazol—Cataract—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0326	CcSEcCtD
Danazol—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0295	CcSEcCtD
Danazol—PGR—hindbrain—amyotrophic lateral sclerosis	0.0111	0.0436	CbGeAlD
Danazol—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00968	0.0258	CcSEcCtD
Danazol—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00964	0.0257	CcSEcCtD
Danazol—ESR1—hindbrain—amyotrophic lateral sclerosis	0.00865	0.0341	CbGeAlD
Danazol—CCL2—medulla oblongata—amyotrophic lateral sclerosis	0.00841	0.0332	CbGeAlD
Danazol—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00833	0.0222	CcSEcCtD
Danazol—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00833	0.0222	CcSEcCtD
Danazol—GNRHR—nervous system—amyotrophic lateral sclerosis	0.00809	0.0319	CbGeAlD
Danazol—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00802	0.0214	CcSEcCtD
Danazol—GNRHR—central nervous system—amyotrophic lateral sclerosis	0.00779	0.0307	CbGeAlD
Danazol—GNRHR—cerebellum—amyotrophic lateral sclerosis	0.00761	0.03	CbGeAlD
Danazol—CCL2—spinal cord—amyotrophic lateral sclerosis	0.0075	0.0296	CbGeAlD
Danazol—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00717	0.0191	CcSEcCtD
Danazol—SHBG—brainstem—amyotrophic lateral sclerosis	0.00703	0.0277	CbGeAlD
Danazol—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00668	0.0178	CcSEcCtD
Danazol—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00666	0.0177	CcSEcCtD
Danazol—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0171	CcSEcCtD
Danazol—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00639	0.017	CcSEcCtD
Danazol—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00636	0.0169	CcSEcCtD
Danazol—CCL2—nervous system—amyotrophic lateral sclerosis	0.00632	0.0249	CbGeAlD
Danazol—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00625	0.0167	CcSEcCtD
Danazol—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00622	0.0166	CcSEcCtD
Danazol—GNRHR—brain—amyotrophic lateral sclerosis	0.00618	0.0244	CbGeAlD
Danazol—CCL2—central nervous system—amyotrophic lateral sclerosis	0.00608	0.024	CbGeAlD
Danazol—CCL2—cerebellum—amyotrophic lateral sclerosis	0.00594	0.0234	CbGeAlD
Danazol—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00588	0.0157	CcSEcCtD
Danazol—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00586	0.0156	CcSEcCtD
Danazol—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00554	0.0148	CcSEcCtD
Danazol—ESR1—embryo—amyotrophic lateral sclerosis	0.00541	0.0213	CbGeAlD
Danazol—Chills—Riluzole—amyotrophic lateral sclerosis	0.00525	0.014	CcSEcCtD
Danazol—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00517	0.0138	CcSEcCtD
Danazol—Tension—Riluzole—amyotrophic lateral sclerosis	0.005	0.0133	CcSEcCtD
Danazol—ESR1—brainstem—amyotrophic lateral sclerosis	0.00496	0.0195	CbGeAlD
Danazol—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00495	0.0132	CcSEcCtD
Danazol—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00493	0.0131	CcSEcCtD
Danazol—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0049	0.0131	CcSEcCtD
Danazol—CCL2—brain—amyotrophic lateral sclerosis	0.00483	0.019	CbGeAlD
Danazol—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0127	CcSEcCtD
Danazol—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00458	0.0122	CcSEcCtD
Danazol—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00457	0.0122	CcSEcCtD
Danazol—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00456	0.0122	CcSEcCtD
Danazol—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0045	0.012	CcSEcCtD
Danazol—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0119	CcSEcCtD
Danazol—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00442	0.0118	CcSEcCtD
Danazol—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0117	CcSEcCtD
Danazol—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0116	CcSEcCtD
Danazol—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0115	CcSEcCtD
Danazol—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00416	0.0111	CcSEcCtD
Danazol—Shock—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0109	CcSEcCtD
Danazol—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0109	CcSEcCtD
Danazol—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0108	CcSEcCtD
Danazol—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0107	CcSEcCtD
Danazol—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00379	0.0101	CcSEcCtD
Danazol—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00996	CcSEcCtD
Danazol—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00976	CcSEcCtD
Danazol—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00956	CcSEcCtD
Danazol—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00948	CcSEcCtD
Danazol—SHBG—central nervous system—amyotrophic lateral sclerosis	0.00355	0.014	CbGeAlD
Danazol—SHBG—cerebellum—amyotrophic lateral sclerosis	0.00347	0.0137	CbGeAlD
Danazol—PGR—nervous system—amyotrophic lateral sclerosis	0.00332	0.0131	CbGeAlD
Danazol—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00881	CcSEcCtD
Danazol—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00877	CcSEcCtD
Danazol—PGR—central nervous system—amyotrophic lateral sclerosis	0.0032	0.0126	CbGeAlD
Danazol—AR—spinal cord—amyotrophic lateral sclerosis	0.00314	0.0124	CbGeAlD
Danazol—PGR—cerebellum—amyotrophic lateral sclerosis	0.00312	0.0123	CbGeAlD
Danazol—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.00299	0.0118	CbGeAlD
Danazol—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00796	CcSEcCtD
Danazol—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00784	CcSEcCtD
Danazol—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.00288	0.0113	CbGeAlD
Danazol—SHBG—brain—amyotrophic lateral sclerosis	0.00282	0.0111	CbGeAlD
Danazol—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00733	CcSEcCtD
Danazol—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00705	CcSEcCtD
Danazol—AR—nervous system—amyotrophic lateral sclerosis	0.00264	0.0104	CbGeAlD
Danazol—Rash—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00699	CcSEcCtD
Danazol—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00698	CcSEcCtD
Danazol—Headache—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00695	CcSEcCtD
Danazol—ESR1—nervous system—amyotrophic lateral sclerosis	0.0026	0.0102	CbGeAlD
Danazol—AR—central nervous system—amyotrophic lateral sclerosis	0.00255	0.01	CbGeAlD
Danazol—PGR—brain—amyotrophic lateral sclerosis	0.00254	0.01	CbGeAlD
Danazol—ESR1—central nervous system—amyotrophic lateral sclerosis	0.0025	0.00986	CbGeAlD
Danazol—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00659	CcSEcCtD
Danazol—ESR1—cerebellum—amyotrophic lateral sclerosis	0.00244	0.00964	CbGeAlD
Danazol—CYP19A1—brain—amyotrophic lateral sclerosis	0.00228	0.00901	CbGeAlD
Danazol—AR—FOXA1 transcription factor network—SOD1—amyotrophic lateral sclerosis	0.00217	0.00584	CbGpPWpGaD
Danazol—PGR—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.00211	0.00568	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.0021	0.00568	CbGpPWpGaD
Danazol—AR—brain—amyotrophic lateral sclerosis	0.00202	0.00798	CbGeAlD
Danazol—ESR1—brain—amyotrophic lateral sclerosis	0.00198	0.00783	CbGeAlD
Danazol—PGR—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.00194	0.00523	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00192	0.00518	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00191	0.00515	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00189	0.00509	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00186	0.00503	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00182	0.00491	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.0018	0.00485	CbGpPWpGaD
Danazol—ESR1—Nuclear signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00175	0.00473	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00171	0.0046	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00169	0.00457	CbGpPWpGaD
Danazol—PGR—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.00167	0.00451	CbGpPWpGaD
Danazol—ESR1—FOXA1 transcription factor network—SOD1—amyotrophic lateral sclerosis	0.00167	0.0045	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00154	0.00415	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00154	0.00414	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.00151	0.00407	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.0015	0.00405	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00148	0.00399	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00145	0.00392	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00145	0.00392	CbGpPWpGaD
Danazol—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00145	0.00572	CbGeAlD
Danazol—CCL2—Oncostatin M Signaling Pathway—VEGFA—amyotrophic lateral sclerosis	0.00144	0.00388	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00143	0.00386	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00143	0.00386	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00143	0.00386	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00143	0.00386	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00142	0.00383	CbGpPWpGaD
Danazol—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00139	0.0055	CbGeAlD
Danazol—CYP19A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00137	0.00369	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.0013	0.0035	CbGpPWpGaD
Danazol—CCL2—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00128	0.00346	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00126	0.00341	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.00124	0.00334	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00121	0.00327	CbGpPWpGaD
Danazol—PGR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00121	0.00327	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00119	0.0032	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.00118	0.00317	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.00114	0.00307	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.00113	0.00305	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00112	0.00302	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.00109	0.00293	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.00108	0.00291	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.00107	0.0029	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.00107	0.00289	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00106	0.00285	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00105	0.00284	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.00105	0.00284	CbGpPWpGaD
Danazol—PGR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00103	0.00278	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00103	0.00277	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.00102	0.00276	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—amyotrophic lateral sclerosis	0.00101	0.00273	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00101	0.00271	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.001	0.00271	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000994	0.00268	CbGpPWpGaD
Danazol—ESR1—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.000981	0.00264	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000966	0.00261	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000963	0.0026	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000946	0.00255	CbGpPWpGaD
Danazol—AR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000924	0.00249	CbGpPWpGaD
Danazol—PGR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000919	0.00248	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000901	0.00243	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000895	0.00241	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000841	0.00227	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000815	0.0022	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000815	0.0022	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000814	0.00219	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000814	0.00219	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000793	0.00214	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000791	0.00213	CbGpPWpGaD
Danazol—AR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000786	0.00212	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	0.000784	0.00211	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000775	0.00209	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000764	0.00206	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000746	0.00201	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000744	0.00201	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000744	0.00201	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00074	0.00199	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000734	0.00198	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000729	0.00196	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000729	0.00196	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000712	0.00192	CbGpPWpGaD
Danazol—AR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000701	0.00189	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000694	0.00187	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.00069	0.00186	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000674	0.00182	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000666	0.0018	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000642	0.00173	CbGpPWpGaD
Danazol—PGR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000637	0.00172	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000629	0.0017	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00062	0.00167	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000612	0.00165	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000605	0.00163	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000603	0.00163	CbGpPWpGaD
Danazol—CYP19A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000603	0.00163	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000601	0.00162	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—amyotrophic lateral sclerosis	0.000596	0.00161	CbGpPWpGaD
Danazol—PGR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000592	0.0016	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000591	0.00159	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000589	0.00159	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000577	0.00155	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000575	0.00155	CbGpPWpGaD
Danazol—PGR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000574	0.00155	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000568	0.00153	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000567	0.00153	CbGpPWpGaD
Danazol—ESR1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00054	0.00146	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000534	0.00144	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000519	0.0014	CbGpPWpGaD
Danazol—Progesterone—SIGMAR1—amyotrophic lateral sclerosis	0.000514	1	CrCbGaD
Danazol—ESR1—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	0.000512	0.00138	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.000511	0.00138	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000506	0.00136	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00049	0.00132	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000488	0.00132	CbGpPWpGaD
Danazol—AR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000486	0.00131	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000485	0.00131	CbGpPWpGaD
Danazol—PGR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000483	0.0013	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000469	0.00126	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000469	0.00126	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000463	0.00125	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000463	0.00125	CbGpPWpGaD
Danazol—AR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000451	0.00122	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000448	0.00121	CbGpPWpGaD
Danazol—AR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000437	0.00118	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000437	0.00118	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000435	0.00117	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00043	0.00116	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000429	0.00116	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000408	0.0011	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000399	0.00108	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000399	0.00107	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000398	0.00107	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000394	0.00106	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000379	0.00102	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000375	0.00101	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000374	0.00101	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00037	0.000997	CbGpPWpGaD
Danazol—AR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000368	0.000992	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00036	0.00097	CbGpPWpGaD
Danazol—ESR1—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000348	0.000938	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.000347	0.000935	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000339	0.000914	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000339	0.000913	CbGpPWpGaD
Danazol—ESR1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000337	0.000908	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000335	0.000904	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000329	0.000887	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000328	0.000883	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000326	0.00088	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000322	0.000868	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00032	0.000864	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000318	0.000858	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000315	0.000848	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000314	0.000848	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000314	0.000846	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000308	0.00083	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000296	0.000797	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000292	0.000788	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000292	0.000787	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000291	0.000784	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000283	0.000764	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000283	0.000762	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000277	0.000748	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000277	0.000747	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00027	0.000729	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000267	0.000719	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000264	0.000712	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000261	0.000703	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000257	0.000692	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000254	0.000684	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000251	0.000677	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000248	0.000669	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000248	0.000669	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000243	0.000656	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000242	0.000653	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000242	0.000651	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000237	0.000639	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000226	0.00061	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000216	0.000582	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000213	0.000573	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000209	0.000564	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000207	0.000558	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000205	0.000554	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000202	0.000544	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000195	0.000525	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000194	0.000524	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000192	0.000518	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000188	0.000507	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000187	0.000505	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000181	0.000487	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000178	0.000481	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000178	0.000479	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000176	0.000475	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000175	0.000472	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000172	0.000463	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000171	0.000462	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000171	0.00046	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000166	0.000447	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.00016	0.000431	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00016	0.000431	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000155	0.000419	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000152	0.000411	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000147	0.000397	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000146	0.000393	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000145	0.00039	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000137	0.000369	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000137	0.000369	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000132	0.000356	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00013	0.000352	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000125	0.000337	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000123	0.000331	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000122	0.000328	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000116	0.000314	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000111	0.0003	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000109	0.000295	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000108	0.000292	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000105	0.000283	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000105	0.000282	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000102	0.000274	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000101	0.000272	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.0001	0.00027	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	9.89e-05	0.000267	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.61e-05	0.000259	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.61e-05	0.000259	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.44e-05	0.000255	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	9.39e-05	0.000253	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	8.94e-05	0.000241	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.63e-05	0.000233	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.34e-05	0.000225	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.91e-05	0.000213	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.65e-05	0.000206	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.49e-05	0.000202	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.2e-05	0.000194	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.13e-05	0.000192	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.92e-05	0.000187	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.52e-05	0.000176	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.42e-05	0.000173	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.36e-05	0.000171	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.06e-05	0.000163	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.92e-05	0.00016	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.68e-05	0.000153	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.44e-05	0.000147	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.42e-05	0.000146	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.89e-05	0.000132	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.11e-05	0.000111	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.77e-05	0.000102	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.56e-05	9.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.2e-05	8.62e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.05e-05	8.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.81e-05	7.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.41e-05	6.51e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.31e-05	6.22e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.58e-05	4.26e-05	CbGpPWpGaD
